You searched for "wearable"

730 results found

Sustainability in ophthalmology and healthcare: An overview

Finally, even staunch sceptics are coming around to recognising that climate change is real and that we should do something about it. But how proximal the threat is and at what pace change has to happen is not universally agreed...

Acetylcholine receptor antibodies in the diagnosis of ocular myasthenia gravis at the Manchester Royal Eye Hospital

Myasthenia gravis (MG) is the commonest autoimmune condition to affect the neuromuscular junction. In the UK, its prevalence is 15 per 10,000 [1,2] and recent studies have shown that rates are steadily increasing [3,4]. Aims of this audit The aim...

The ROP Network: a south-south collaboration to improve care for premature babies

Retinopathy of prematurity (ROP) is a disorder of the immature preterm retina and a leading cause of preventable, irreversible blindness in children. There are 15 million preterm births annually, and over 32,000 neonates became blind from ROP in 2010 [1]....

An update on inherited retinal disorders (part 1) – overview and assessment of inherited retinal disease

Part 2 of this topic can be found here Inherited Retinal Disease (IRD) is the leading cause of blindness certification in the working age population (age 16-64 years) in England and Wales and the second most common in childhood [1]....

Study reveals increase in Charles Bonnet Syndrome symptoms due to COVID-19

A study published today in BMJ Open Ophthalmology has shown the impact of COVID-19 on those already experiencing vivid hallucinations as a result of Charles Bonnet syndrome (CBS).

Global eyecare charity Orbis welcomes new international president and CEO

NGO leader Kathleen Sherwin joins Orbis International to meet the growing global demand for eyecare. Global eye care NGO Orbis International is pleased to welcome Kathleen Sherwin as the organisation’s new President and CEO.Kathleen brings more than 25 years of...

Neovascular AMD: fresh recommendations underline standards of best practice

The management of neovascular age-related macular degeneration (nAMD) has advanced dramatically over the past seven years, with the introduction of targeted new therapies that successfully maintain or improve vision in a majority of affected individuals. It’s a fast moving field,...

Major survey calls for new ideas on how to reinvent post diagnostic support for blind and partially sighted people

The Royal National Institute of Blind People (RNIB) is launching a new research study to better understand post-diagnostic support across the sight loss sector. People who have experienced being diagnosed with a sight condition know it’s not always easy to...

The vitreoretinal priesthood

When I first started doing cataract lists, the consultant at the time, a Mr Brown from Carmarthen, used to say that phacoemulsification was more akin to flying a jet fighter for short dangerous bombing runs than a boring long haul...

Training the trainers

Learning phakoemulsification is a psychologically demanding process. Every ophthalmologist passing through the UK training system will almost certainly have many stories to tell of difficulties faced along the way; hideous disasters where lessons were learnt, as well as glorious triumphs...

Beginning to flag

Have you signed the petition yet?” the nurse asked me. I am generally a type of person who signs a lot of petitions whilst being cynical that they do anything at all for anyone, including the person who signs them,...

Efficacy of intravitreal dexamethasone implant in patients with persistent macular oedema

Chronic cystoid macular oedema (CME) can develop secondary to various pathologies such as diabetic maculopathy, retinal vein occlusion and uveitis. It can cause significant visual impairment and macular damage. The therapeutic effect of corticosteroids in CME is through one or...